Adial Pharmaceuticals Inc (NASDAQ: ADIL)
$1.0150
-0.0050 ( -1.46% ) 64.9K
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Market Data
Open
$1.0150
Previous close
$1.0200
Volume
64.9K
Market cap
$6.60M
Day range
$0.9950 - $1.0700
52 week range
$0.7650 - $4.1699
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Nov 18, 2024 |
| 3 | Insider transactions | 2 | Nov 18, 2024 |
| sc | Insider transactions | 1 | Nov 14, 2024 |
| 10-q | Quarterly Reports | 60 | Nov 13, 2024 |
| 8-k | 8K-related | 14 | Nov 12, 2024 |
| 8-k | 8K-related | 18 | Nov 05, 2024 |
| ars | Annual reports | 1 | Sep 30, 2024 |
| def | Proxies and info statements | 6 | Sep 27, 2024 |
| 10-q | Quarterly Reports | 61 | Aug 13, 2024 |
| 10-q | Quarterly Reports | 61 | May 14, 2024 |